Stratifying triple-negative breast cancer: which definition(s) to use?

Summary

Triple-negative breast cancer (TNBC) shows a paradox: better response to neoadjuvant chemotherapy but worse prognosis. New research suggests Ki-67 levels may define TNBC subgroups with different outcomes.